APPLIED THERAPEUTICS INC. - COMMON STOCK

Applied Therapeutics Receives Orphan Medicinal Product Designation from the EMA for AT-007 for Treatment of Galactosemia

03 Jun 2022 07:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the UBS Global Healthcare Conference

19 May 2022 07:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Reports First Quarter 2022 Financial Results

12 May 2022 06:59:25 By Nasdaq GlobeNewswire

Applied Therapeutics to Present Data on AT-007 Treatment in SORD Deficiency at the 2022 Annual Meeting of the Peripheral Nerve Society

05 May 2022 07:30:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 43rd Annual Meeting of the Society for Inherited Metabolic Disorders

04 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 2022 Annual Clinical Genetics Meeting of the American College of Molecular Genetics and Genomics

16 Mar 2022 07:30:00 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results

10 Mar 2022 07:30:01 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the Cowen and Barclays Investor Conferences

01 Mar 2022 07:00:02 By Nasdaq GlobeNewswire

Applied Therapeutics Supports 15th Annual Rare Disease Day

28 Feb 2022 07:30:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

10 Feb 2022 07:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Provides Regulatory Update on Galactosemia Program

03 Jan 2022 07:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of AT-007 in SORD Deficiency

16 Dec 2021 07:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism

18 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD Deficiency

25 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia Kids

18 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia Kids

09 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

Applied Therapeutics Reports Second Quarter 2021 Financial Results

12 Aug 2021 07:00:02 By Nasdaq GlobeNewswire

Applied Therapeutics Added to Russell Microcap® Index

28 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic Cardiomyopathy at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association

25 Jun 2021 12:05:54 By Nasdaq GlobeNewswire

Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association

21 Jun 2021 07:00:00 By Nasdaq GlobeNewswire